From owner-freebsd-stable@FreeBSD.ORG Fri Aug 8 09:31:03 2003 Return-Path: Delivered-To: freebsd-stable@freebsd.org Received: from mx1.FreeBSD.org (mx1.freebsd.org [216.136.204.125]) by hub.freebsd.org (Postfix) with ESMTP id 3A4EF37B401 for ; Fri, 8 Aug 2003 09:31:03 -0700 (PDT) Received: from mail.smed.com (mail.smed.com [64.46.248.225]) by mx1.FreeBSD.org (Postfix) with ESMTP id 5A0B343FA3 for ; Fri, 8 Aug 2003 09:31:02 -0700 (PDT) (envelope-from Joseph.Warner@siemens.com) Received: from smtpgate.smshsc.net (smtpgate.smshsc.net [165.226.204.25]) by mail.smed.com (Postfix) with ESMTP id CA49C48555 for ; Fri, 8 Aug 2003 12:31:01 -0400 (EDT) Received: from MLVV9MBA.ww005.siemens.net (mlvv9mba.smshsc.net [165.226.204.44]) by smtpgate.smshsc.net (8.11.6/8.11.6) with ESMTP id h78GV1i10643 for ; Fri, 8 Aug 2003 12:31:01 -0400 Received: from mlvexc01.smshsc.net ([165.226.249.73]) by 165.226.204.44 with InterScan Messaging Security Suite; Fri, 08 Aug 2003 12:28:28 -0400 Received: by MLVEXC01 with Internet Mail Service (5.5.2656.59) id ; Fri, 8 Aug 2003 12:30:59 -0400 Message-ID: From: Warner Joseph To: "'freebsd-stable@freebsd.org'" Date: Fri, 8 Aug 2003 12:30:53 -0400 MIME-Version: 1.0 X-Mailer: Internet Mail Service (5.5.2656.59) Content-Type: text/plain; charset="iso-8859-1" Subject: 2 Questions X-BeenThere: freebsd-stable@freebsd.org X-Mailman-Version: 2.1.1 Precedence: list List-Id: Production branch of FreeBSD source code List-Unsubscribe: , List-Archive: List-Post: List-Help: List-Subscribe: , X-List-Received-Date: Fri, 08 Aug 2003 16:31:03 -0000 Hi, Just two quick questions: 1. Would it be possible or difficult to upgrade FreeBSD 4.8 -STABLE to 5.2 -STABLE when it comes out? 2. Which is the best for a production environment, -STABLE or -RELEASE Someone told me they think the latter is better because it doesn't require as much downtime for an upgrade. Thanks Joe ------------------------------------------------------------------------------- This message and any included attachments are from Siemens Medical Solutions USA, Inc. and are intended only for the addressee(s). The information contained herein may include trade secrets or privileged or otherwise confidential information. Unauthorized review, forwarding, printing, copying, distributing, or using such information is strictly prohibited and may be unlawful. If you received this message in error, or have reason to believe you are not authorized to receive it, please promptly delete this message and notify the sender by e-mail with a copy to CSOffice@smed.com. Thank you